Twelve per cent of 6142 eyes treated for neovascular age‐related macular degeneration (nAMD) presented with low visual outcome within 2 years. Analysis from the Swedish Macula Registry (SMR)

PURPOSE: To analyse characteristics from the SMR to explore the risk factors for visual acuity (VA) below ≤ 35 letters of the Early Treatment Diabetic Retinopathy Study (ETDRS) due to nAMD during a two‐year follow‐up. METHODS: This study evaluates 6142 treatment‐naïve eyes, with focus on a subgroup...

Descripción completa

Detalles Bibliográficos
Autores principales: Schroeder, Marion, Westborg, Inger, Lövestam Adrian, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216980/
https://www.ncbi.nlm.nih.gov/pubmed/31517440
http://dx.doi.org/10.1111/aos.14239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216980/
https://www.ncbi.nlm.nih.gov/pubmed/31517440
http://dx.doi.org/10.1111/aos.14239

Ejemplares similares